Network interactions in schizophrenia - therapeutic implications (Q73553195)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Network interactions in schizophrenia - therapeutic implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Carlsson A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Waters N

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Waters S

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Carlsson ML

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

342-349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

The current status of the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Presynaptic dopaminergic function in the striatum of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

On the Quantitative Structure-Activity Relationships of Meta-Substituted (S)-Phenylpiperidines, a Class of Preferential Dopamine D2 Autoreceptor Ligands: Modeling of Dopamine Synthesis and Release in Vivo by Means of Partial Least Squares Regression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

The role of 5-HT2A receptors in antipsychotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

(+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Muscimol: GABA agonist therapy in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900050-8

7 January 2021

10.1016/S0165-0173(99)00050-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10719161%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference